A concerning number of newly diagnosed patients discontinue their medication within a year. Nearly 40% of patients diagnosed ...

Novo Nordisk shares have dropped ~50% since June 2024 due to poor trial results and other negative catalysts. See why I rate ...

A new analysis of FDA adverse event reports suggests a potential link between tirzepatide and thyroid cancer. Learn what this ...

Singer Meghan Trainor is opening up about the weight loss drug she took to lose weight, but it might not be a good idea. The ...

Drinks sweetened with sucralose (sold as Splenda) increased hunger compared with drinks made with sugar in a new study.

Perez Hilton has struggled with weight management for decades. Now, he’s spreading the word about the benefits of GLP-1 drugs ...

The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain ...

How the culture distinguishes health care choices between natural based medicinal options and evidence-based ...

If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

Meanwhile, the first major obesity-related phase 3 trial for orforglipron is set to complete in July. If the data from the ...

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 ...